Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Latency-Reversing Agents Induce Differential Responses in Distinct Memory CD4 T Cell Subsets in Individuals on Antiretroviral Therapy
Marion Pardons, Rémi Fromentin, Amélie Pagliuzza, et al.
Cell Reports (2019) Vol. 29, Iss. 9, pp. 2783-2795.e5
Open Access | Times Cited: 58

Showing 26-50 of 58 citing articles:

Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places
Wenxuan Chen, Ben Berkhout, Alexander Pasternak
Current HIV/AIDS Reports (2025) Vol. 22, Iss. 1
Open Access
β-catenin regulates HIV latency and modulates HIV reactivation
Hannah J. Barbian, Melanie S. Seaton, Srinivas D. Narasipura, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 3, pp. e1010354-e1010354
Open Access | Times Cited: 18
New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
Catherine A. Lewis, David M. Margolis, Edward P. Browne
Viruses (2023) Vol. 15, Iss. 8, pp. 1677-1677
Open Access | Times Cited: 9
The ingenol-based protein kinase C agonist GSK445A is a potent inducer of HIV and SIV RNA transcription
Afam A. Okoye, Rémi Fromentin, Hiroshi Takata, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 1, pp. e1010245-e1010245
Open Access | Times Cited: 15
Experimental Systems for Measuring HIV Latency and Reactivation
Koh Fujinaga, Daniele C. Cary
Viruses (2020) Vol. 12, Iss. 11, pp. 1279-1279
Open Access | Times Cited: 21
Integrated Assessment of Viral Transcription, Antigen Presentation, and CD8+T Cell Function Reveals Multiple Limitations of Class I-Selective Histone Deacetylase Inhibitors during HIV-1 Latency Reversal
Talia M. Mota, Chase D. McCann, Ali Danesh, et al.
Journal of Virology (2020) Vol. 94, Iss. 9
Open Access | Times Cited: 20
The Combination of Venetoclax and Ixazomib Selectively and Efficiently Kills HIV-Infected Cell Lines but Has Unacceptable Toxicity in Primary Cell Models
Alecia Alto, Sekar Natesampillai, Aswath P. Chandrasekar, et al.
Journal of Virology (2021) Vol. 95, Iss. 12
Open Access | Times Cited: 17
The Intact Noninducible Latent HIV-1 Reservoir Is Established in an In Vitro Primary T CM Cell Model of Latency
Indra Sarabia, Szu-Han Huang, Adam R. Ward, et al.
Journal of Virology (2021) Vol. 95, Iss. 7
Open Access | Times Cited: 16
Impact of IL-15 and latency reversing agent combinations in the reactivation and NK cell-mediated suppression of the HIV reservoir
Daniela Angela Covino, Maria Giovanna Desimio, Margherita Doria
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
The active human immunodeficiency virus reservoir during antiretroviral therapy: emerging players in viral persistence
Antonio Astorga-Gamaza, María J. Buzón
Current Opinion in HIV and AIDS (2021) Vol. 16, Iss. 4, pp. 193-199
Open Access | Times Cited: 15
Human Immunodeficiency Virus-1 Latency Reversal via the Induction of Early Growth Response Protein 1 to Bypass Protein Kinase C Agonist-Associated Immune Activation
Lilly Wong, Dajiang Li, Yuyang Tang, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 9
Principles and Applications of CRISPR Toolkit in Virus Manipulation, Diagnosis, and Virus-Host Interactions
Saleh Jamehdor, Sara Pajouhanfar‎, Sadaf Saba, et al.
Cells (2022) Vol. 11, Iss. 6, pp. 999-999
Open Access | Times Cited: 8
Rethinking IL-1 Antagonism in Respiratory Viral Infections: A Role for IL-1 Signaling in the Development of Antiviral T Cell Immunity
Bram Van Den Eeckhout, Marlies Ballegeer, Jozefien De Clercq, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15770-15770
Open Access | Times Cited: 4
Combinations of Histone Deacetylase Inhibitors with Distinct Latency Reversing Agents Variably Affect HIV Reactivation and Susceptibility to NK Cell-Mediated Killing of T Cells That Exit Viral Latency
Daniela Angela Covino, Maria Giovanna Desimio, Margherita Doria
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6654-6654
Open Access | Times Cited: 10
Immunotherapeutic approaches to HIV cure and remission
Ming Lee, Sarah Fidler, John Frater
Current Opinion in Infectious Diseases (2021) Vol. 35, Iss. 1, pp. 31-41
Open Access | Times Cited: 10
Combination therapies currently under investigation in phase I and phase II clinical trials for HIV-1
Hanh Thi Pham, Subin Yoo, Thibault Mésplède
Expert Opinion on Investigational Drugs (2020) Vol. 29, Iss. 3, pp. 273-283
Closed Access | Times Cited: 8
Hydrogen sulfide blocks HIV rebound by maintaining mitochondrial bioenergetics and redox homeostasis
Virender Kumar Pal, Ragini Agrawal, Srabanti Rakshit, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 8
Combinatorial Use of Both Epigenetic and Non-Epigenetic Mechanisms to Efficiently Reactivate HIV Latency
Joseph Hokello, Adhikarimayum Lakhikumar Sharma, Mudit Tyagi
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3697-3697
Open Access | Times Cited: 7
IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation
Ifeanyi Jude Ezeonwumelu, Edurne García-Vidal, Eudald Felip, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4
Single-Cell Multiparametric Analysis of Rare HIV-Infected Cells Identified by Duplexed RNAflow-FISH
Mathieu Dubé, Daniel E. Kaufmann
Methods in molecular biology (2022), pp. 291-313
Closed Access | Times Cited: 3
More than a Gender Issue: Testis as a Distinctive HIV Reservoir and Its Implication for Viral Eradication
Jean‐Pierre Routy, Franck P. Dupuy, John Lin, et al.
Methods in molecular biology (2022), pp. 173-186
Closed Access | Times Cited: 3
Nanoparticle delivery of Tat synergizes with classical latency reversal agents to express HIV antigen targets
Samuel L M Raines, Shane D. Falcinelli, Jackson J. Peterson, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 7
Closed Access
High concentrations of Maraviroc do not alter immunological and metabolic parameters of CD4 T cells
Humberto Erick de la Torre-Tarazona, Caroline Passaes, Santiago Moreno, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
DOT1L/H3K79me2 represses HIV-1 reactivation via recruiting DCAF1
Fenfei Liang, Jiaxing Jin, Qiming Li, et al.
Cell Reports (2024) Vol. 43, Iss. 7, pp. 114368-114368
Open Access
A Canadian Survey of Research on HIV-1 Latency—Where Are We Now and Where Are We Heading?
Ana Luiza Abdalla, Gabriel Guajardo-Contreras, Andrew J. Mouland
Viruses (2024) Vol. 16, Iss. 2, pp. 229-229
Open Access

Scroll to top